BTK Inhibitors in Other B-cell Lymphomas

The changing landscape of BTK-targeted therapies for B-cell lymphomas and CLLПодробнее

Update on CAR T-Cell Therapy | Lymphoma Research Foundation WebinarsПодробнее

Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell LymphomaПодробнее

How to Treat Follicular & Mantle Cell Lymphomas - Discussion with Dr. Pallawi TorkaПодробнее

Expert Recommendations for Treating CLL With BTK InhibitorsПодробнее

Samarth | BTK inhibitor in CLL | 11.06.2024Подробнее

Selecting between BTK inhibitors in MCL & addressing resistance to these agentsПодробнее

APPlexus Hot Topics 2024: Clinical Updates on Non-Covalent BTK Inhibitors in CLL and MCLПодробнее

Symposium | First-line BTK inhibitors for CLL: Current and future perspectivesПодробнее

Update on Mantle Cell Lymphoma Webinar | Lymphoma Research Foundation WebinarsПодробнее

Solving the Puzzles for B-Cell Malignancies: Navigating the Place of BTK Inhibitors Today and Tom...Подробнее

Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cel...Подробнее

B-Cell Malignancies: Why Not All BTK Inhibitors Are Created EqualПодробнее

Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell LymphomaПодробнее

What's New for BTK Inhibitors in B-Cell Malignancies? A Winter Hematology Conference Update Подробнее

What Clinicians Want to Know About Toxicity Considerations Associated with BTK InhibitorsПодробнее

Mantle Cell Lymphoma | Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with ...Подробнее

Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?Подробнее

Chronic Lymphocytic Leukemia and Lymphoma | Oncology Today with Dr Neil Love: Special Edition — K...Подробнее

Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a symposium in partnership with NCO...Подробнее